Price forecast: Range-bound ahead? Reckitt Benckiser trades near $5,794 on mixed momentum

Traders Union
All News
Financial News
Reckitt benckiser slips 0.58% today

Highlights

Reckitt Benckiser repurchased 60,120 shares on October 31, 2025, at $5,804–$5,848 to reduce outstanding shares and tighten supply, signaling shareholder return focus.
Shares trade just below the MA-20 at $5,794.00, above the MA-50 at $5,703.48, confirming a bullish medium- and long-term technical setup despite marginal short-term selling pressure.
Weekly indicators (RSI, ADX, MACD, MA-50) support an over 80% probability of price increase, with a projected five-day range of $5,746.00–$5,886.00.

Share buyback and insider purchase reinforce capital return focus

Reckitt Benckiser repurchased 60,120 ordinary shares on October 31, 2025, at prices between $5,804 and $5,848 each, holding these in treasury to reduce outstanding shares and support the price by tightening supply. This action highlights a focus on capital return to shareholders. Additionally, insider Patricia Verduin bought 135 shares on October 29, 2025, reflecting management's confidence in the company.

Mixed momentum signals as intraday volatility stays muted

Momentum is mixed: MACD remains firmly bullish, but ADX at 25.65 signals only moderate trend strength. RSI on the daily chart sits at 56.24 (neutral-buy), while Stoch RSI is deeply oversold and CCI is neutral, highlighting a divergence between short-term weakness and underlying positive bias. BBP’s overbought reading and a mild daily decline (down $34.00 or 0.58%) suggest buyers have recently lost some grip. The gap at the open was minimal, and the price is now near today’s low within a narrow $5,788.00 – $5,846.00 range, reflecting low intraday volatility and pressure after the open. The awesome oscillator is neutral, and the blend of oversold/overbought signals underscores a lack of clear directional conviction in today’s session.

Bullish breakout odds rise as key weekly signals align

Looking ahead, the expected five-day price range is $5,746.00 to $5,886.00. The probability of an increase is very high (more than 80%) given all weekly signals (RSI, ADX, MACD, MA-50) remain firmly bullish. A decline is thus much less likely. The baseline scenario anticipates continued trading within a sideways corridor with support at $5,735.00 (Kijun); a bullish scenario would see a sustained breakout above MA-50 near $5,703.48 and potentially targeting $5,886.00, while a bearish outcome would only unfold if $5,735.00 support fails, exposing further downside to $5,703.00 and below.

Anton Kharitonov, analyst at Traders Union, notes that Reckitt Benckiser’s current price action reveals modest selling pressure in the short term but maintains bullish underpinnings over the medium- to long-term as technicals stay constructive above key moving averages. He emphasizes the significance of the company’s timely share buyback and insider purchase, which indicate a deliberate effort to bolster shareholder value and suggest internal confidence despite recent neutral-to-weak momentum and mixed oscillator signals. Kharitonov remains cautious due to the lack of strong directional conviction and persistent intraday weakness. "Base case is sideways consolidation above $5,735.00, but if this support fails, I expect downside toward $5,703.00 and see little reason to be aggressive in current conditions."

Previously it was noted that mixed momentum and oscillator signals suggested a consolidation phase, with the stock expected to continue trading within a set corridor as sideways bias expected as upside breakout risk persisted. Additionally, strong institutional ownership and insider buying were seen as supporting factors for the underlying trend.

Source of Data: RKT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.